Coronavirus and COVID-19: The latest news and views from the scientific community about the new coronavirus and COVID-19.
PDF (English)

Palavras-chave

SARS-CoV-2
USA
Spain
Italy
China
Wuhan
Literature review
Transmission
Pandemia
Covid-19
Coronavirus

Como Citar

Coelho Paraguassu, E. ., Chen, H. ., Zhou, F. ., Xu, Z. ., & Wang, M. . (2020). Coronavirus and COVID-19: The latest news and views from the scientific community about the new coronavirus and COVID-19. Brazilian Journal of Implantology and Health Sciences, 2(3), 96–109. https://doi.org/10.36557/2674-8169.2020v2n3p96-109

Resumo

Introduction: Coronavirus is a family of viruses that cause respiratory infections. The new coronavirus agent was discovered on 12/31/19 after cases registered in China. It causes the disease called coronavirus (COVID-19). The first human coronaviruses were isolated for the first time in 1937. However, it was in 1965 that the virus was described as coronavirus, due to the profile under microscopy, looking like a crown.

Objectives: This article aims to bring the most current medical literature on the coronavirus pandemic (COVID-19).

Methodology: The publications with the greatest impact factor in  February and March 2020 were searched in Nature, Elservie, JAMA and Wiley.

Results: More than 200 articles on COVID-19 were found and 20 articles were selected with the highest number of citations on Google Scholar.

Conclusion: Until March 2020, there is no really effective treatment against COVID-19, but many medications are being tested and with very promising results. The concern with the economy is also an extremely relevant factor at this moment.

https://doi.org/10.36557/2674-8169.2020v2n3p96-109
PDF (English)

Referências

1. Chan, J. F. W., Yuan, S., Kok, K. H., To, K. K. W., Chu, H., Yang, J., ... & Tsoi, H. W. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, 395(10223), 514-523.
2. Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D. Y., Chen, L., & Wang, M. (2020). Presumed asymptomatic carrier transmission of COVID-19. Jama.
3. Novel, C. P. E. R. E. (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi, 41(2), 145.
4. Ou, X., Liu, Y., Lei, X. et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11, 1620 (2020). https://doi.org/10.1038/s41467-020-15562-9
5. Wu, J.T., Leung, K., Bushman, M. et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med (2020). https://doi.org/10.1038/s41591-020-0822-7
6. Andersen, K.G., Rambaut, A., Lipkin, W.I. et al. The proximal origin of SARS-CoV-2. Nat Med (2020). https://doi.org/10.1038/s41591-020-0820-9
7. Wan, Y., Shang, J., Graham, R., Baric, R. S. & Li, F. J. Virol. https://doi.org/10.1128/JVI.00127-20 (2020).
8. Thevarajan, I., Nguyen, T.H.O., Koutsakos, M. et al. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med (2020). https://doi.org/10.1038/s41591-020-0819-2.
9. Shang, W., Yang, Y., Rao, Y. et al. The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. npj Vaccines 5, 18 (2020). https://doi.org/10.1038/s41541-020-0170-0.
10. Letko, M., Marzi, A. & Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 5, 562–569 (2020). https://doi.org/10.1038/s41564-020-0688-y.
11. Wu, F., Zhao, S., Yu, B. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265–269 (2020). https://doi.org/10.1038/s41586-020-2008-3
12. Zhou, P., Yang, X., Wang, X. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020). https://doi.org/10.1038/s41586-020-2012-7
13. Chater, N. Facing up to the uncertainties of COVID-19. Nat Hum Behav (2020). https://doi.org/10.1038/s41562-020-0865-2
14. Betsch, C. How behavioural science data helps mitigate the COVID-19 crisis. Nat Hum Behav (2020). https://doi.org/10.1038/s41562-020-0866-1
15. van Staden, C. COVID-19 and the crisis of national development. Nat Hum Behav (2020). https://doi.org/10.1038/s41562-020-0852-7
16. Ting, D.S.W., Carin, L., Dzau, V. et al. Digital technology and COVID-19. Nat Med (2020). https://doi.org/10.1038/s41591-020-0824-5
17. Hindson, J. COVID-19: faecal–oral transmission?. Nat Rev Gastroenterol Hepatol (2020). https://doi.org/10.1038/s41575-020-0295-7
18. Hu, TY, Frieman, M. e Wolfram, J. Insights da nanomedicina sobre a eficácia da cloroquina contra COVID-19. Nat. Nanotechnol. (2020). https://doi.org/10.1038/s41565-020-0674-9
19. Paul Adepoju. Nigeria responds to COVID-19; first case detected in sub-Saharan Africa. Nature Medicine. (2020). doi: 10.1038/d41591-020-00004-2
20. Zheng, Y., Ma, Y., Zhang, J. et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol (2020). https://doi.org/10.1038/s41569-020-0360-5

INTEREST CONFLICTS
The authors declare no conflicts of interest
Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.

Copyright (c) 2020 Brazilian Journal of Implantology and Health Sciences